BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26358738)

  • 1. Targeting Inflammation Through a Physical Active Lifestyle and Pharmaceuticals for the Treatment of Type 2 Diabetes.
    Knudsen SH; Pedersen BK
    Curr Diab Rep; 2015 Oct; 15(10):82. PubMed ID: 26358738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise and type 2 diabetes: focus on metabolism and inflammation.
    Karstoft K; Pedersen BK
    Immunol Cell Biol; 2016 Feb; 94(2):146-50. PubMed ID: 26568029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease.
    Pedersen BK
    Eur J Clin Invest; 2017 Aug; 47(8):600-611. PubMed ID: 28722106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit?
    Maiorino MI; Bellastella G; Giugliano D; Esposito K
    Endocrine; 2017 Feb; 55(2):360-365. PubMed ID: 27230767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic inflammation can cause type 2 diabetes].
    Sjöholm A; Nyström T
    Lakartidningen; 2004 May; 101(19):1716-21. PubMed ID: 15188586
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of the anti-inflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model.
    Hazman Ö; Ovalı S
    Inflammation; 2015; 38(3):1012-9. PubMed ID: 25411096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?
    Sathyapalan T; Atkin SL
    Minerva Endocrinol; 2011 Jun; 36(2):147-56. PubMed ID: 21519323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
    Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Protective Role of Glibenclamide in Inflammation-Associated Injury.
    Zhang G; Lin X; Zhang S; Xiu H; Pan C; Cui W
    Mediators Inflamm; 2017; 2017():3578702. PubMed ID: 28740332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spleen-Derived Anti-Inflammatory Cytokine IL-10 Stimulated by Adipose Tissue-Derived Stem Cells Protects Against Type 2 Diabetes.
    Zhang J; Deng Z; Jin L; Yang C; Liu J; Song H; Han W; Si Y
    Stem Cells Dev; 2017 Dec; 26(24):1749-1758. PubMed ID: 29032727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control.
    Scheen AJ; Esser N; Paquot N
    Diabetes Metab; 2015 Jun; 41(3):183-94. PubMed ID: 25794703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control.
    Pedersen BK
    Essays Biochem; 2006; 42():105-17. PubMed ID: 17144883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of rosiglitazone on inflammatory reaction and insulin resistance in obese patients with newly diagnosed type 2 diabetes].
    Zhu HL; Yu RM; Huang XZ; Huang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1050-1. PubMed ID: 18583261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes.
    Kuryłowicz A; Koźniewski K
    Molecules; 2020 May; 25(9):. PubMed ID: 32397353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes.
    Ndisang JF; Jadhav A
    Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.